[Remote] Principal Software Engineer - Computational Chemistry / Molecular Dynamics at Genesis Therapeutics

New York, New York, United States

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, Artificial IntelligenceIndustries

Skills

Key technologies and capabilities for this role

Computational ChemistryDrug DiscoveryMachine LearningBiophysical SimulationSoftware DevelopmentAPI DevelopmentWorkflow AutomationData InfrastructureParallel ComputingMentoringProject Leadership

Questions & Answers

Common questions about this position

Is this position remote?

Yes, this is a remote position.

What is the salary for this role?

This information is not specified in the job description.

What skills and experience are required for this Principal Software Engineer role?

Candidates need a deep background in computational chemistry, experience in computational chemistry and drug discovery, writing production code, working across the software stack, handling complex computational chemistry workflows, data infrastructure for large datasets, and leading/mentoring engineers.

What is the company culture like at Genesis Therapeutics?

The company unifies AI and biotech with a team of accomplished biotech leaders, expert drug hunters, deep learning researchers, and software engineers pioneering molecular AI technologies, focused on building a world-class software team.

What makes a strong candidate for this position?

A strong candidate has a deep background in computational chemistry, experience productionizing workflows for drug discovery, ability to lead and mentor cross-disciplinary engineers, and provide technical insights on software architecture.

Genesis Therapeutics

AI-driven drug discovery for pharmaceuticals

About Genesis Therapeutics

Genesis Therapeutics accelerates the development of new medicines by using artificial intelligence in drug discovery. The company combines 3D spatial graph modeling and molecular simulation to identify potential drug candidates and explore new chemical spaces. Unlike its competitors, Genesis Therapeutics focuses on strategic partnerships with other biotech and pharmaceutical companies, generating revenue through upfront payments and future earnings based on drug success. The goal is to transform the drug discovery process and bring new therapies to market.

Burlingame, CaliforniaHeadquarters

2019Year Founded

$272.5MTotal Funding

SERIES_BCompany Stage

AI & Machine Learning, BiotechnologyIndustries

51-200Employees

Benefits

Competitive salary

Equity

Medical, dental, & vision insurance

401(k) program

Risks

Competition from AI-driven companies like Insilico Medicine and Exscientia is increasing.

Over-reliance on partnerships could lead to financial instability if drugs aren't successful.

Rapid AI advancements may render current models like GEMS obsolete without updates.

Differentiation

Genesis Therapeutics uses AI to accelerate drug discovery with 3D spatial graph modeling.

The GEMS platform integrates deep learning, molecular simulations, and generative AI for drug design.

Strategic partnerships with Eli Lilly and Gilead highlight Genesis' industry collaboration strength.

Upsides

Partnership with NVIDIA enhances GEMS platform for targeting undruggable diseases.

$224 million equity investment boosts research and development capabilities.

Recognition as a 'Fierce 15' company underscores AI's role in breakthrough therapeutics.

Land your dream remote job 3x faster with AI

Try Jobo Free